文献速递介入外周血管儿科影像CTMRUS

经皮冷冻消融治疗四肢血管异常的安全性、可行性与技术成功率

Safety, feasibility, and technical success of percutaneous cryoablation to treat vascular anomalies of the extremities.
PubMed 文献 · Clin Radiol · 2025-07-11

这项回顾性研究纳入8例四肢血管异常患者(7例儿童、1例成人),评估经皮冷冻消融的安全性及疗效。技术成功8例均达成,8例随访均报告疼痛减轻,影像随访见病灶缩小;11次治疗中发生1例(9%)主要不良事件为皮肤水疱,6周内自愈。作者认为冷冻消融似乎有效且安全,尤其对手术或硬化治疗无效者。

要点

  • 四肢血管异常经皮冷冻消融技术成功率高,本组8例均达成预设消融目标。
  • 8例随访均报告疼痛减轻,影像随访病例可见病灶缩小。
  • 11次治疗中1例(9%)发生主要不良事件,为皮肤水疱,6周内自愈。

核心结论

  • 作者认为,冷冻消融对血管异常患者似乎是一种有效且安全的治疗,尤其对既往手术或硬化治疗无效者,本组8例中有7例属于这种情况。

研究设计与样本

  • 回顾性研究,纳入8例四肢血管异常患者(7例儿童1–18岁、1例成人45岁;6女2男),7例血管畸形、1例血管肿瘤,共11次治疗。

诊断标准与关键数值

  • 技术成功定义为按预设次数将冷冻治疗送达目标解剖部位并达成术前目标,本组8例均技术成功。
  • 不良事件按欧洲心血管与介入放射学会不良事件分级标准分类。
  • 11次治疗中发生1例(9%)主要不良事件,为皮肤水疱,6周内自愈,后续治疗耐受良好;其余术后不良反应轻微且短暂,所有并发症及术后不良反应2个月内自愈。

临床应用与阅片要点

  • 作者认为,冷冻消融对血管异常患者似乎有效且安全,尤其对既往手术或硬化治疗无效者,本组8例中有7例。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIM: This retrospective study aims to ascertain the safety and efficacy of percutaneous cryoablation in treating vascular anomalies in the extremities.

MATERIALS AND METHODS: Anomaly characteristics and safety metrics were extracted from the chart including complications classified according to the Cardiovascular and Interventional Radiological Society of Europe adverse event scale. Technical success was defined as achieving preprocedural goals in delivering cryotherapy to the targeted anatomy in the prescribed number of sessions. Clinical outcome metrics included assessment of reported symptom improvement and objective improvement on imaging.

RESULTS: Eight patients met the selection criteria: seven paediatric patients aged 1-18 years and one adult patient aged 45 years, including six females and two males. Seven patients had vascular malformations and one had a vascular tumour. The most common presenting symptoms included localised pain, swelling, and loss of extremity function. Technical success was achieved in all eight patients. Reduction of pain was reported in all eight patients at follow-up in a clinic. Reduction of lesion size on imaging was seen for patients undergoing follow-up imaging. One major adverse event occurred in 11 treatment sessions (9%) resulting in a dermal blister with subsequent spontaneous healing within 6 weeks; a subsequent session was tolerated without incident. Other postoperative adverse effects were minor and transient; all complications and postoperative adverse effects resolved spontaneously within 2 months.

CONCLUSION: Cryoablation appears to be an effective and safe treatment in those with vascular anomalies, especially in those previously ineffectively treated with surgery or sclerotherapy, as was seen in seven of eight patients in this study.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Mahler C, DiFatta J, Mitta P, et al. Safety, feasibility, and technical success of percutaneous cryoablation to treat vascular anomalies of the extremities. Clin Radiol. 2025. PMID: 40811976. doi:10.1016/j.crad.2025.107017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。